Impact of PD-1 inhibitor therapy on population incremental health outcome gain for patients with esophageal squamous cell carcinoma in China
1.Department of GI Cancer Center Surgery Unit Ⅲ, Key laboratory of Carcinogenesis and Translational Research, Peking University Cancer Hospital & Institute, Beijing 100142, China
2.Medical Insurance Department, Key laboratory of Carcinogenesis and Translational Research, Peking University Cancer Hospital & Institute, Beijing 100142, China
3.Health Economics Research Institute, School of Pharmaceutical Sciences, Sun yat-sen University, Guangzhou 510006, China
收起